External Source

Efficacy Of Acoramidis On All Cause Mortality And Cardiovascular Hospitalization In Transthyretin Am

2025 16:29
Synopsis
Dr Jean-Jacques VON HUNOLSTEIN : Cardiologue Hôpital Civil Strasbourg.

You Might Also Like

AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care 4:30
Aha 2024 And Acoramidis: Impact On The Future Of Attr-cm Pat...
2025
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025 6:00
Breaking New Ground: Acoramidis Reduces Af Events In Attr Cm...
2025
The impact of acoramidis on clinical outcomes in ATTR-CM 0:50
The Impact Of Acoramidis On Clinical Outcomes In Attr-cm
2024
Cardiomyopathy: TTR Amyloid: efficacy and safety of acoramidis in transthyretin amyloid cardiomyo... 6:06
Cardiomyopathy: Ttr Amyloid: Efficacy And Safety Of Acoramid...
2024
ESC 23: ATTRibute-CM Trial 4:40
Esc 23: Attribute-cm Trial
2023
The CardioNerds, Dr. Dan Judge Assess the ATTRibute-CM Trial 7:00
The Cardionerds, Dr. Dan Judge Assess The Attribute-cm Trial
2025
Acoramidis Treatment is Effective in Patients With ATTR-CM 2:43
Acoramidis Treatment Is Effective In Patients With Attr-cm
2024
Acoramidis Reduces AF Burden in ATTR-CM: ESC 2025 Insights 3:30
Acoramidis Reduces Af Burden In Attr-cm: Esc 2025 Insights
2025
Bibliose du 15 mai 2025 - 13h30 1:20:34
Bibliose Du 15 Mai 2025 - 13h30
2025
"Tafamidis for Cardiac Amyloidosis: A Breakthrough in Reducing Mortality and Hospitalizations" 2:58
"tafamidis For Cardiac Amyloidosis: A Breakthrough In Reduci...
2024
Acoramidis improves outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) 2:42
Acoramidis Improves Outcomes In Patients With Transthyretin ...
2023
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.